Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for RAPT

Stock Name	RAPT Therapeutics Inc
Ticker	RAPT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75382E1091
LEI	549300MB473BIU78ES48

Show aggregate RAPT holdings

News associated with RAPT

Analysts Set Rapt Therapeutics (NASDAQ:RAPT) PT at $21.57: Rapt Therapeutics (NASDAQ:RAPT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating on the […] - 2025-08-20 03:10:52
Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT): Two Sigma Investments LP lowered its holdings in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 65.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,465 shares of the company’s stock after selling 339,957 shares during the period. […] - 2025-06-12 04:28:52
Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT): Millennium Management LLC cut its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 23.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 737,704 shares of the company’s stock after selling 222,261 shares during the period. Millennium Management LLC’s holdings in RAPT Therapeutics were worth $1,166,000 as of its most recent filing […] - 2025-06-05 04:42:43
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Two Sigma Advisers LP: Two Sigma Advisers LP trimmed its stake in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 28.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 503,700 shares of the company’s stock after selling 201,300 shares during the quarter. Two Sigma Advisers […] - 2025-06-03 04:56:52
Geode Capital Management LLC Raises Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT): Geode Capital Management LLC lifted its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 716,937 shares of the company’s stock after purchasing an additional 33,758 shares during the period. Geode Capital […] - 2025-05-01 04:30:59
Analysts Set RAPT Therapeutics, Inc. (NASDAQ:RAPT) PT at $5.29: RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the […] - 2025-02-26 04:22:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) RAPT holdings

Date	Number of RAPT Shares Held	Base Market Value of RAPT Shares	Local Market Value of RAPT Shares	Change in RAPT Shares Held	Change in RAPT Base Value	Current Price per RAPT Share Held	Previous Price per RAPT Share Held
2026-02-09 (Monday)	20,762	USD 1,199,421	USD 1,199,421
2026-02-06 (Friday)	20,716	USD 1,195,106	USD 1,195,106	46	USD 2,860	USD 57.69	USD 57.68
2026-02-02 (Monday)	20,670	USD 1,192,246	USD 1,192,246	0	USD 0	USD 57.68	USD 57.68
2026-01-30 (Friday)	20,670	USD 1,192,246	USD 1,192,246	92	USD 6,336	USD 57.68	USD 57.63
2026-01-29 (Thursday)	20,578	USD 1,185,910	USD 1,185,910	46	USD 3,061	USD 57.63	USD 57.61
2026-01-27 (Tuesday)	20,532	USD 1,182,849	USD 1,182,849	46	USD 2,446	USD 57.61	USD 57.62
2026-01-26 (Monday)	20,486	USD 1,180,403	USD 1,180,403	0	USD -205	USD 57.62	USD 57.63

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RAPT by Blackrock for IE00BYXG2H39

Show aggregate share trades of RAPT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-02-06 BUY 46 57.690* 19.90
2026-01-30 BUY 92 57.800 57.625 57.642 USD 5,303 18.62
2026-01-29 BUY 46 57.690 57.590 57.600 USD 2,650 17.94
2026-01-27 BUY 46 57.660 57.580 57.588 USD 2,649 17.25
2026-01-23 BUY 92 57.670 57.630 57.634 USD 5,302 15.78
2026-01-22 BUY 46 57.705 57.610 57.620 USD 2,650 15.01
2026-01-16 BUY 1,348 35.450 32.000 32.345 USD 43,601 12.50
2026-01-15 BUY 86 34.940 32.080 32.366 USD 2,783 12.10
2026-01-14 BUY 86 35.420 33.955 34.101 USD 2,933 11.62
2026-01-12 BUY 86 34.520 32.140 32.378 USD 2,785 10.64
2026-01-09 BUY 129 33.720 32.060 32.226 USD 4,157 10.13
2026-01-07 BUY 86 33.240 31.080 31.296 USD 2,691 9.12
2026-01-02 BUY 43 34.150 31.620 31.873 USD 1,371 7.49
2025-12-30 BUY 43 35.950 33.010 33.304 USD 1,432 6.12
2025-12-23 SELL -516 36.725 35.100 35.262 USD -18,195 2.65 Loss of -16,829 on sale
2024-11-18 SELL -870 8.800 9.760 9.664 USD -8,408 2.15 Loss of -6,534 on sale
2024-11-08 SELL -58 23.120 25.120 24.920 USD -1,445 2.13 Loss of -1,322 on sale
2024-10-21 SELL -58 13.160 14.560 14.420 USD -836 0.00 Loss of -836 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-02-06	BUY	46			57.690*		19.90
2026-01-30	BUY	92	57.800	57.625	57.642	USD 5,303	18.62
2026-01-29	BUY	46	57.690	57.590	57.600	USD 2,650	17.94
2026-01-27	BUY	46	57.660	57.580	57.588	USD 2,649	17.25
2026-01-23	BUY	92	57.670	57.630	57.634	USD 5,302	15.78
2026-01-22	BUY	46	57.705	57.610	57.620	USD 2,650	15.01
2026-01-16	BUY	1,348	35.450	32.000	32.345	USD 43,601	12.50
2026-01-15	BUY	86	34.940	32.080	32.366	USD 2,783	12.10
2026-01-14	BUY	86	35.420	33.955	34.101	USD 2,933	11.62
2026-01-12	BUY	86	34.520	32.140	32.378	USD 2,785	10.64
2026-01-09	BUY	129	33.720	32.060	32.226	USD 4,157	10.13
2026-01-07	BUY	86	33.240	31.080	31.296	USD 2,691	9.12
2026-01-02	BUY	43	34.150	31.620	31.873	USD 1,371	7.49
2025-12-30	BUY	43	35.950	33.010	33.304	USD 1,432	6.12
2025-12-23	SELL	-516	36.725	35.100	35.262	USD -18,195	2.65 Loss of -16,829 on sale
2024-11-18	SELL	-870	8.800	9.760	9.664	USD -8,408	2.15 Loss of -6,534 on sale
2024-11-08	SELL	-58	23.120	25.120	24.920	USD -1,445	2.13 Loss of -1,322 on sale
2024-10-21	SELL	-58	13.160	14.560	14.420	USD -836	0.00 Loss of -836 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RAPT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	44,472	0	383,750	11.6%
2025-09-18	110,534	0	215,503	51.3%
2025-09-17	41,411	0	63,181	65.5%
2025-09-16	39,993	0	81,493	49.1%
2025-09-15	32,684	0	67,865	48.2%
2025-09-12	24,780	0	292,600	8.5%
2025-09-11	31,129	0	57,640	54.0%
2025-09-10	31,420	0	72,140	43.6%
2025-09-09	20,162	0	29,943	67.3%
2025-09-08	22,035	0	53,383	41.3%
2025-09-05	23,854	0	41,566	57.4%
2025-09-04	38,815	0	51,287	75.7%
2025-09-03	7,221	0	20,623	35.0%
2025-09-02	8,200	0	15,566	52.7%
2025-08-29	4,861	0	5,835	83.3%
2025-08-28	8,264	0	47,309	17.5%
2025-08-27	7,041	0	78,477	9.0%
2025-08-26	7,094	0	43,457	16.3%
2025-08-25	7,178	0	19,445	36.9%
2025-08-22	2,645	0	16,392	16.1%
2025-08-21	7,642	0	29,414	26.0%
2025-08-20	15,182	0	49,477	30.7%
2025-08-19	11,006	0	16,565	66.4%
2025-08-18	6,727	16	113,604	5.9%
2025-08-15	10,456	10	151,234	6.9%
2025-08-14	12,225	0	19,213	63.6%
2025-08-13	8,921	0	514,271	1.7%
2025-08-12	18,460	2,341	536,415	3.4%
2025-08-11	8,109	0	16,284	49.8%
2025-08-08	5,397	60	12,362	43.7%
2025-08-07	10,487	0	15,270	68.7%
2025-08-06	5,548	0	8,218	67.5%
2025-08-05	7,227	0	11,409	63.3%
2025-08-04	11,859	2,808	12,602	94.1%
2025-08-01	6,858	12	13,948	49.2%
2025-07-31	7,289	0	16,040	45.4%
2025-07-30	9,059	97	12,697	71.3%
2025-07-29	12,370	330	23,701	52.2%
2025-07-28	10,885	0	18,071	60.2%
2025-07-25	20,367	485	32,300	63.1%
2025-07-24	19,275	510	38,638	49.9%
2025-07-23	41,366	2,333	61,635	67.1%
2025-07-22	12,647	16	25,342	49.9%
2025-07-21	19,855	1	36,542	54.3%
2025-07-18	45,869	0	78,319	58.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE